Correction-Treatment of The Platelet Hyper-aggregability

About the Book

This book presents a very effective new treatment-method for migraine, vertigo, dizziness and syncope that is found by the author. In addition, the author discovered a reliable method for the prevention of dementia, that is the continuous correction (lowering exactly to normal aggregability) of the platelet hyper-aggregability (this means the ability of the platelet is too strong).

The author found a high incidence of hyper-aggregability in these diseases. And, after the correction-treatment, headache, vertigo, dizziness improve or disappear within one to two months in the large majority of patients.

This method is epoch making. Almost all of patients who showed platelet hyper-aggregability remain symptom-free from intractable migraine, vertigo after the correction and became very healthy, and are very pleased to this treatment.

This treatment shows dramatic effect, so that many of my patients enjoy active daily lives, though the usual medicine was too ineffective for them. This is a fundamental treatment based on the cause of the disease.

The platelet hyper-aggregability is found to be the major cause and creates the white matter lesions, and finally it become the Binswanger’s dementia, in which there is severe and wide white matter lesion, it consisted about half of all dementias.

Since the platelet hyper-aggregability correction can largely prevent to 1/4 the development and progress of white matter lesions, the appearance of dementia can be largely delayed and it will reduce by half the occurrence of all dementia.

In dementia, platelet hyper-aggregability is found at the high rate. And, if the platelet hyper-aggregability is corrected, dementia becomes better.

Platelet hyper-aggregability is a big risk factor for a small artery; its importance is almost equal to hypertension.

Besides, it must be related to other undistinguished many diseases.

This method that I found is an extremely wonderful thing for humankind.

About the Author

Dr. Shigekiyo Fujita is Director, Institute for Advanced Neurological Medicine and Computed Imaging, in Ishikawa Hospital, Himeji, Japan.

He is board-certified in neurological medicine such as for migraine, vertigo, dementia and stroke.

He graduated Kobe Medical College. He received his medical degree from Kobe University School of Medicine’s Post-Graduate Course (on Neurophysiology). Formerly, he was an Associate Professor of Neurosurgery at Kobe University School of Medicine, and Director of Department of Neurosurgery and Vice President of Hyogo Brain and Heart Center at Himeji.

He wrote 153 Papers: (33 English Papers) and 4 Medical Monographs.

He lives in Himeji, Japan.